Christoph westphal longwood
WebJun 6, 2024 · The Boston-area biotech entrepreneur says he will remain as chairman of Flex Pharma, but as of July 3, he will vacate the CEO role to focus on his venture firm, the Longwood Fund. WebAt Longwood, our team finds strength in our diverse backgrounds and passion for innovation. We’re a team of doctors, investors, entrepreneurs, scientists, and life-long learners who are committed to discovering and …
Christoph westphal longwood
Did you know?
WebDr. Westphal is co-founder and General Partner of Longwood Fund and has spent 20 years as a biotech CEO, entrepreneur, and investor. Dr. Westphal has been the co … Christoph Westphal was the company’s Co-Founder and startup CEO and … WebLONGWOOD HEALTHCARE LEADERS WINTER CONFERENCE AGENDA JANUARY 6-7, 2024 THURSDAY, JANUARY 6, 2024 7:00 am PT / 10:00 am ET LONGWOOD FUND INTRODUCTION. Christoph Westphal, General Partner, Longwood Fund 7:30 am PT / 10:30 am ET NEWCO TO ESTABLISHED: BUILDING A BIOTECH
WebChristoph Westphal’s Post Christoph Westphal reposted this Report this post Report Report. Back Submit. Longwood Healthcare Leaders 682 followers 34m Now in-person at ... WebJun 23, 2024 · As part of the financing, Christoph Westphal, M.D., Ph.D., Founding CEO, DEM Bio, and Founding Partner Longwood Fund; Dan Janney, Managing Partner, ... Founded by Longwood Fund, the company’s ...
WebJul 24, 2024 · Editor & Founder Christoph Westphal has closed the fifth in a series of funds for Longwood with $170 million to play with. That’s not a blockbuster by any means in this day and age, but it... WebDec 18, 2024 · He succeeds founding CEO, Christoph Westphal, M.D, Ph.D., who assumes the role of Chairman of the Board of Directors. ... Immunitas Therapeutics, founded by Longwood Fund, employs a single cell ...
WebNov 10, 2024 · TScan was co-founded by Chair Christoph Westphal (Partner, Longwood Fund) based on pioneering research from the Elledge Lab at Brigham and Women’s Hospital. The Company has raised over $80 million to date from leading strategic collaborators and investors including Longwood Fund, Novartis Institutes for Biomedical …
WebJul 23, 2024 · Alongside Longwood Fund’s General Partners Christoph Westphal, David Steinberg and Rich Aldrich, and CFO John Lawrence, the Firm has a strong team of … ing polin e c spaWebChristoph Westphal, M.D., Ph.D. 2. Check the Appropriate Box if a Member of a Group (See Instructions) ... L.P., Longwood Fund II GP, LLC, Longwood Fund III GP, LLC, Christoph Westphal, M.D., Ph.D., and Richard Aldrich, (collectively, the “Reporting Persons”), pursuant to §240.13d-2(a), to amend the Schedule 13D filed by the Reporting ... mitylite chair cartmitylite chairs meshWebAug 5, 2024 · Westphal has been the co-founder, CEO, and lead investor of six biotechnology companies that have completed initial public offerings. The relationship … ing poperinge telefoonWebApr 26, 2024 · TScan was formed in 2024 when Christoph Westphal's venture capital firm, The Longwood Fund, licensed technology from decorated Harvard geneticist Stephen Elledge that uses T-cell receptors ... mityhome.comWebDr. Westphal has been the co-founder, CEO, and lead investor of six biotechnology companies that have completed initial public offerings. The relationship combines … ing postbus 50052 6800 rc arnhemWebDec 7, 2024 · Longwood Fund-Christoph Westphal Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. and ML Strategies-R. Robert Popeo Morgan, Lewis, & Brockius LLP-Steven C. Browne Needham Bank-Joseph P. Campanelli. BENEFACTORS Locke Lord LLP WuXi AppTec Manatt, Phelps, & Phillips, LLP-Scott T. Lashway. PATRONS ingpors s.r.o